Q1 2021 Holdings
Filed 2021-05-17 | 48 holdings | $935.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $267.8M | 7,440,107 | 28.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $124.2M | 880,000 | 13.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $111.8M | 2,165,000 | 12.0% |
| Codexis Inc(CDXS) | COM | 192005106 | $99.1M | 4,330,000 | 10.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $81.3M | 1,193,335 | 8.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $65.5M | 818,820 | 7.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $52.2M | 150,000 | 5.6% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $46.3M | 1,150,000 | 4.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $45.9M | 1,300,000 | 4.9% |
| Alector Inc(ALEC) | COM | 014442107 | $33.2M | 1,650,000 | 3.6% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $5.5M | 726,511 | 0.6% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $466.3K | 12,203,669 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $311.0K | 2,360,186 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $280.3K | 3,400,000 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $166.6K | 5,000,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $150.7K | 1,550,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $123.9K | 1,000,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $116.7K | 3,375,058 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $91.9K | 1,610,000 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $88.6K | 1,745,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $84.6K | 1,844,535 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $45.9K | 1,611,214 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $43.2K | 995,354 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $42.1K | 1,800,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $41.0K | 550,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $39.6K | 3,346,034 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $36.7K | 900,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $32.5K | 266,430 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $25.4K | 190,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $23.3K | 3,215,434 | 0.0% |
| Burning Rock Biotech LTD | SPONSORED ADR | 12233L107 | $22.8K | 847,150 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $22.4K | 1,000,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $21.8K | 2,211,622 | 0.0% |
| 908 Devices Inc(MASS) | COM | 65443P102 | $19.7K | 406,502 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $17.1K | 583,436 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $16.7K | 820,440 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $14.7K | 601,515 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $14.6K | 1,241,176 | 0.0% |
| Decibel Therapeutics Inc | COM | 24343R106 | $13.0K | 1,146,421 | 0.0% |
| Berkeley LTS Inc(BLIUSD) | COM | 084310101 | $10.0K | 200,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $9.5K | 610,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $7.5K | 150,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $7.1K | 75,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $6.9K | 550,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.7K | 120,000 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $2.9K | 216,216 | 0.0% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $2.0K | 60,000 | 0.0% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $1.2K | 76,688 | 0.0% |